Overview

Lumason® Infusion vs. Bolus Administrations

Status:
NOT_YET_RECRUITING

Trial end date:
2024-12-31

Target enrollment:

Participant gender:

Summary

A phase III study designed as a randomized, within-patient comparison of continuous infusion of diluted Lumason® versus the bolus administration of undiluted Lumason® for degree of LVO and assessment of LV EBD (co-primary endpoints).

Phase:

PHASE3

Details

Lead Sponsor:

Bracco Diagnostics, Inc

Treatments:

Suspensions